About IPM Biotech
IPM Biotech was established in 2008 in Hamburg, Germany, within the biotechnology sector. Equipment for cytometry, PCR, and ELISA, along with biomarkers, is produced by the company. Operations are centered on supplying tools for laboratory and research applications in medical diagnostics. The firm is led by CEO Euan Menzies, with activities based in Germany to serve European markets.
- Headquarter Hamburg, Germany
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
- Investors
-
Employee Count
Not available
-
Acquired by
BioAgilytix
(Feb 22, 2016)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of IPM Biotech
Detailed funding history for IPM Biotech
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in IPM Biotech
IPM Biotech has secured backing from 1 investor. Prominent investors backing the company include BioAgilytix.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Large-molecule bioanalysis is provided for biologics and biosimilars development.
|
Locked | Locked | Locked |
Investor details for IPM Biotech
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by IPM Biotech
Investment portfolio details for IPM Biotech
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - IPM Biotech
Detailed financials for IPM Biotech
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Ipm Biotech Comparisons
Peer comparison for IPM Biotech
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of IPM Biotech
Detailed competitors of IPM Biotech
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Ipm Biotech
Complete news archive for IPM Biotech
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about IPM Biotech
IPM Biotech was founded in 2008.
IPM Biotech is headquartered in Hamburg, Germany. It is registered at Hamburg, Hamburg, Germany.
Euan Menzies is the current CEO of IPM Biotech.
IPM Biotech was established in 2008 in Hamburg, Germany, within the biotechnology sector. Equipment for cytometry, PCR, and ELISA, along with biomarkers, is produced by the company. Operations are centered on supplying tools for laboratory and research applications in medical diagnostics. The firm is led by CEO Euan Menzies, with activities based in Germany to serve European markets.
IPM Biotech has 1 investor. Key investors include BioAgilytix.